Tanya Trakarnphornsombat
@watanyatra.bsky.social
📤 20
📥 48
📝 0
Postdoctoral Training Fellow at the Institute of Cancer Research, London
reposted by
Tanya Trakarnphornsombat
Alex Radzisheuskaya
8 months ago
So proud of Dan for winning the poster prize — and it was his very first poster! What a great start!
add a skeleton here at some point
0
4
1
reposted by
Tanya Trakarnphornsombat
Alex Radzisheuskaya
11 months ago
The Transcription and Chromatin UK Meeting is back for 2025! Don't miss out — register your interest:
www.biochemistry.org/events-and-t...
@biochemsoc.bsky.social
loading . . .
Transcription and Chromatin UK 2025
Transcription and Chromatin UK brings together the rich transcription and epigenetics community in the UK and leading experts from abroad, and will feature all aspects of transcription and chromatin r...
https://www.biochemistry.org/events-and-training/events-calendar/transcription-and-chromatin-uk-2025/
0
3
2
reposted by
Tanya Trakarnphornsombat
Konrad Chudzik
10 months ago
🚨 Preprint alert 🚨 Excited to share our work on "Ab-trapping," an antibody artifact causing misleading peripheral ("rim") staining in imaging & genomics (IF, CUT&Tag, CUT&RUN). Antibodies fail to penetrate structures, accumulating at the periphery. A 🧵👇
doi.org/10.1101/2025...
loading . . .
Ab-trapping - a peripheral staining artifact in antibody-based microscopy and genomics
Antibodies (Ab) are essential for detecting specific epitopes in microscopy and genomics, but can produce artifacts leading to erroneous interpretations. Here, we characterize a novel artifact, Ab-tra...
https://doi.org/10.1101/2025.04.09.648027
2
69
50
reposted by
Tanya Trakarnphornsombat
Eric Topol
about 1 year ago
CRISPR genome editing clicks for amyloid cardiomyopathy.
nejm.org/doi/full/10....
A Phase 1 study with marked reduction of serum TTR
loading . . .
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy | NEJM
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly i...
https://nejm.org/doi/full/10.1056/NEJMoa2412309
2
121
17
reposted by
Tanya Trakarnphornsombat
Kristian Helin
about 1 year ago
Follow the Institute of Cancer Research on our new Bluesky account. Moving from X -
@icrlondon.bsky.social
0
13
8
you reached the end!!
feeds!
log in
